Spravato® (esketamine) nasal spray is an FDA-approved, breakthrough treatment for adults with treatment-resistant depression who have not found relief with traditional antidepressants. Unlike standard medications, Spravato works on the NMDA receptor in the brain, helping to rapidly restore neural connections associated with mood regulation. At Zephyr Medical, Spravato is administered in a comfortable, medically supervised setting by experienced clinical staff, with each treatment plan carefully tailored to the individual patient. Our goal is to provide safe, effective, and compassionate care while offering new hope to those struggling with persistent depression.